These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2877129)

  • 1. Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Leuven JA; Schouten JA; Stalenhoef AF
    Lancet; 1986 Oct; 2(8513):936-9. PubMed ID: 2877129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia.
    Mol MJ; Erkelens DW; Gevers Leuven JA; Schouten JA; Stalenhoef AF
    Atherosclerosis; 1988 Feb; 69(2-3):131-7. PubMed ID: 3279966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin (MK 733) in heterozygous familial hypercholesterolemia: a two-year trial.
    Leclercq V; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):76-81. PubMed ID: 2921098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between simvastatin and bezafibrate in effect on plasma lipoproteins and apolipoproteins in primary hypercholesterolaemia.
    Schulzeck P; Bojanovski M; Jochim A; Canzler H; Bojanovski D
    Lancet; 1988 Mar; 1(8586):611-3. PubMed ID: 2894548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.
    Mabuchi H; Haba T; Tatami R; Miyamoto S; Sakai Y; Wakasugi T; Watanabe A; Koizumi J; Takeda R
    N Engl J Med; 1981 Aug; 305(9):478-82. PubMed ID: 7254297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synvinolin in hypercholesterolaemia.
    Olsson AG; Mölgaard J; von Schenk H
    Lancet; 1986 Aug; 2(8503):390-1. PubMed ID: 2874382
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels.
    Wiklund O; Angelin B; Fager G; Eriksson M; Olofsson SO; Berglund L; Lindén T; Sjöberg A; Bondjers G
    J Intern Med; 1990 Sep; 228(3):241-7. PubMed ID: 2119417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine.
    Betteridge DJ; Bhatnager D; Bing RF; Durrington PN; Evans GR; Flax H; Jay RH; Lewis-Barned N; Mann J; Matthews DR
    BMJ; 1992 May; 304(6838):1335-8. PubMed ID: 1611329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation.
    Dirisamer A; Hachemian N; Bucek RA; Wolf F; Reiter M; Widhalm K
    Eur J Pediatr; 2003 Jun; 162(6):421-5. PubMed ID: 12756561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MK-733 on plasma lipid and lipoprotein levels in subjects with hypercholesterolaemia.
    Simons LA; Nestel PJ; Calvert GD; Jennings GL
    Med J Aust; 1987 Jul; 147(2):65-8. PubMed ID: 3299016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial.
    Stein EA; Gipe D; Bergeron J; Gaudet D; Weiss R; Dufour R; Wu R; Pordy R
    Lancet; 2012 Jul; 380(9836):29-36. PubMed ID: 22633824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Sexton GJ
    J Clin Invest; 1984 Dec; 74(6):1972-8. PubMed ID: 6569064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.
    Grundy SM; Bilheimer DW
    Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2538-42. PubMed ID: 6371816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary management of patients with familial hypercholesterolaemia treated with simvastatin.
    Chisholm A; Mann J; Sutherland W; Williams S; Ball M
    Q J Med; 1992; 85(307-308):825-31. PubMed ID: 1484945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of the HMG-CoA-reductase inhibitor pravastatin in hyperlipoproteinaemia type II.
    Saxenhofer H; Weidmann P; Riesen WF; Beretta-Piccoli C; Fragiacomo C; Wunderlin R; Noseda G
    Eur J Clin Pharmacol; 1990; 39(2):101-5. PubMed ID: 2123791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.
    Mol MJ; Stuyt PM; Demacker PN; Stalenhoef AF
    Neth J Med; 1990 Apr; 36(3-4):182-90. PubMed ID: 2355995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CS-514, a new inhibitor of HMG CoA reductase, on plasma lipids, lipoproteins and apoproteins in patients with primary hypercholesterolemia.
    Kazumi T; Yoshino G; Kasama T; Iwatani I; Iwai M; Morita S; Baba S
    Horm Metab Res; 1986 Sep; 18(9):654-5. PubMed ID: 3096862
    [No Abstract]   [Full Text] [Related]  

  • 19. Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.
    Raal FJ; Santos RD; Blom DJ; Marais AD; Charng MJ; Cromwell WC; Lachmann RH; Gaudet D; Tan JL; Chasan-Taber S; Tribble DL; Flaim JD; Crooke ST
    Lancet; 2010 Mar; 375(9719):998-1006. PubMed ID: 20227758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia.
    Raal FJ; Pilcher GJ; Illingworth DR; Pappu AS; Stein EA; Laskarzewski P; Mitchel YB; Melino MR
    Atherosclerosis; 1997 Dec; 135(2):249-56. PubMed ID: 9430375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.